France· FR:62076503
NOXAFIL 40 mg/mL, suspension buvable
A posaconazole product containing posaconazole, registered in France by MERCK SHARP & DOHME (PAYS-BAS). The same ATC class is registered in 18 of our 19 countries.
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
Where it is registered
Posaconazole is registered in 18 of 19 countries.
Countries holding a registration under ATC J02AC04 (posaconazole), each read from that country’s own register.
- This record: France, from Base de données publique des médicaments — BDPM (France)
- 10 of them publish a price we can compare per daily dose
Posaconazole · ATC J02AC04
18 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Italyprice
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of posaconazole costs, country by country.
Normalised to the WHO defined daily dose (0.3 g), the median price runs from $6.09 in United States to $82.67 in Italy — a ×14 gap.
- 3 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
- US figures are pharmacy acquisition cost (CMS NADAC), not retail
Posaconazole · price per daily dose (0.3 g)
USD · FX 28 Sept 2026
- IT Italy$82.67
- CH Switzerland$74.94
- US United States$6.09 (acquisition cost)
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- POSACONAZOLE
- Manufacturer
- MERCK SHARP & DOHME (PAYS-BAS)
- Country
- France (FR)
- ATC code
- J02AC04
- ATC class
- Posaconazole
- Defined daily dose
- 0.3 g, O
- Reimbursed
- No
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 1
- cip1334009370239861 flacon(s) en verre jaune(brun) de 105 ml avec fermeture de sécurité enfant avec cuillère-mesure polystyrène
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
415 interactions on record for posaconazole.
Graded by severity as the source publishes them — 143 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Posaconazole · interactions on record
415 records
- 143 severe
- 219 moderate
- 7 minor
- 27 info
Most severe, free to view
- PapaverineA03AD01severe
- CisaprideA03FA02severe
- DolasetronA04AA04severe
- NaloxegolA06AH03severe
19 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Posaconazole in 17 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- PolandNoxafilMerck Sharp & Dohme B.V.
- NetherlandsNoxafil 40 mg/ml suspensie voor oraal gebruikMerck Sharp & Dohme B.V.
- FinlandNoxafilMerck Sharp & Dohme B.V.
- United StatesNOXAFILMerck Sharp & Dohme LLC
- SpainNOXAFIL 40 MG/ML SUSPENSION ORALMerck Sharp & Dohme B.V.
- SwedenNoxafil 40 mg/ml Oral suspensionMerck Sharp & Dohme BV
- ItalyNOXAFILMERCK SHARP & DOHME BV
- IcelandNoxafilMerck Sharp & Dohme B.V.*
Authorised across Europe · EMA
The same active substance is authorised in 27 EEA countries. Names it is sold under:
- Austria · Posaconazol Altan, Posaconazol Ratiopharm
- Belgium · Posaconazol Ab, Posaconazol Sandoz
- Czechia · Gudivin, Posaconazole Accord
- Germany · Ossmiq, Posaconazol
- Denmark · Posaconazol Stada, Posaconazol Teva B.V.
- Estonia · Ossmiq, Posaconazol
- Spain · Posaconazol, Posaconazol Abdi
- Finland · Posaconazol Vivanta, Posaconazole
- United Kingdom (Northern Ireland) · Posaconazol Msn Laboratories, Posaconazole
- Greece · Posaconazole Genepharm, Posaconazole Stada
- Croatia · Posakonazol Abdi, Posakonazol Msn
- Hungary · Gudivin, Posaconazol Accord
- Ireland · Posaconazole, Posaconazole Teva
- Iceland · Noxafil, Posaconazole Accord
- Italy · Posaconazole Eg Stada, Posaconazole Mylan
- Liechtenstein · Noxafil, Posaconazole Accord
- Lithuania · Posaconazole Stada
- Latvia · Posaconazole Stada
- Malta · Posaconazole, Posaconazole Anfarm
- Netherlands · Posaconazol 100 Mg, Posaconazol Abdi
- Norway · Noxafil, Posaconazole Accord
- Poland · Posaconazole Accord, Posaconazole Aurovitas
- Portugal · Posaconazol Almovar, Posaconazol Anfarm
- Romania · Posaconazol, Posaconazol Accord
- Sweden · Posaconazole, Posaconazole Amarox
- Slovenia · Posaconazol Msn, Posakonazol Stada
- Slovakia · Posaconazol Msn, Posaconazole Msn
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/ff5826c6-7cc4-43c5-bbfd-77aea1b845ce GET /v1/drugs/ff5826c6-7cc4-43c5-bbfd-77aea1b845ce?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "62076503",
"date_amm": "2005-10-25",
"type_amm": "Procédure centralisée",
"numero_ue": "EU/1/05/320",
"substance": "POSACONAZOLE",
"atc_source": "fr_atc_restore_2026-09-06",
"statut_amm": "Autorisation active",
"statut_bdm": "Warning disponibilité",
"forme_pharmaceutique": "suspension buvable",
"voies_administration": "orale",
"etat_commercialisation": "Non commercialisée",
"surveillance_renforcee": "Non"
}See everything about posaconazole.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.